Effect of a very late antigen‐4 receptor antagonist on allergen‐induced airway responses and inflammation in asthma

Background Very late antigen‐4 (VLA4) plays a key role in the recruitment of eosinophils in allergic responses in animal studies.

[1]  B. Jensen,et al.  Pharmacoscintigraphic Comparison of HMR 1031, a VLA-4 Antagonist, in Healthy Volunteers Following Delivery Via a Nebulizer and a Dry Powder Inhaler , 2004, American journal of therapeutics.

[2]  B. Jensen,et al.  Effect of Food on Pharmacokinetics of an Inhaled Drug: A Case Study with a VLA‐4 Antagonist, HMR1031 , 2003, Journal of clinical pharmacology.

[3]  M. Robinson,et al.  The effect of anti-integrin monoclonal antibodies on antigen-induced pulmonary inflammation in allergic rabbits. , 2003, Pulmonary pharmacology & therapeutics.

[4]  P. O'Byrne,et al.  Allergen‐induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation , 2003, Immunology.

[5]  W. Hagmann,et al.  A small molecule very late antigen-4 antagonist can inhibit ovalbumin-induced lung inflammation. , 2003, American journal of respiratory and critical care medicine.

[6]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[7]  A. Zwinderman,et al.  Asymptomatic worsening of airway inflammation during low-dose allergen exposure in asthma: protection by inhaled steroids. , 2002, American journal of respiratory and critical care medicine.

[8]  P. Sterk,et al.  Standardised methodology of sputum induction and processing , 2002, European Respiratory Journal.

[9]  David Y Jackson,et al.  Alpha 4 integrin antagonists. , 2002, Current pharmaceutical design.

[10]  H. Popper,et al.  Expression of adhesion molecules in allergic lung diseases , 2002, Virchows Archiv.

[11]  K. Konstantopoulos,et al.  CCR3-Active Chemokines Promote Rapid Detachment of Eosinophils from VCAM-1 In Vitro1 , 2000, The Journal of Immunology.

[12]  R. Djukanović,et al.  The relationship between airways inflammation and asthma severity. , 2000, American journal of respiratory and critical care medicine.

[13]  J. Vandenbroucke,et al.  Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. , 1999, American journal of respiratory and critical care medicine.

[14]  D. Staunton,et al.  αdβ2 Integrin Is Expressed on Human Eosinophils and Functions as an Alternative Ligand for Vascular Cell Adhesion Molecule 1 (VCAM-1) , 1998, The Journal of experimental medicine.

[15]  K C Lin,et al.  Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents. , 1998, Current opinion in chemical biology.

[16]  M. Elices,et al.  Blockade of late-phase airway responses and airway hyperresponsiveness in allergic sheep with a small-molecule peptide inhibitor of VLA-4. , 1997, American journal of respiratory and critical care medicine.

[17]  P. Barnes,et al.  Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. , 1997, The European respiratory journal.

[18]  S. Kharitonov,et al.  Exhaled and nasal nitric oxide measurements : recommendations , 1997 .

[19]  P. Sterk,et al.  Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. , 1996, The European respiratory journal.

[20]  M. Jordana,et al.  Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation. , 1996, American journal of respiratory and critical care medicine.

[21]  E. Knol,et al.  Mechanisms regulating eosinophil extravasation in asthma. , 1996, The European respiratory journal. Supplement.

[22]  P. O'Byrne,et al.  Reproducibility of allergen-induced early and late asthmatic responses. , 1995, The Journal of allergy and clinical immunology.

[23]  P. Sterk,et al.  The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. , 1995, The Journal of allergy and clinical immunology.

[24]  S. Anderson,et al.  Airway responsiveness : standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults , 1993 .

[25]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[26]  Z. Tomori,et al.  Comparison of inspiratory effort in sniff-like aspiration reflex, gasping and normal breathing in cats. , 1993, The European respiratory journal.

[27]  R. Djukanović,et al.  Mucosal inflammation in asthma. , 1990, The American review of respiratory disease.

[28]  D. Cockcroft,et al.  Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. , 2015, The American review of respiratory disease.